- Home
- EXAS vs EXP Comparison
EXAS vs EXP Comparison
Compare EXAS & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- EXP
- Stock Information
- Founded
- EXAS 1995
- EXP 1963
- Country
- EXAS United States
- EXP United States
- Employees
- EXAS N/A
- EXP N/A
- Industry
- EXAS Medical Specialities
- EXP Building Materials
- Sector
- EXAS Health Care
- EXP Industrials
- Exchange
- EXAS Nasdaq
- EXP Nasdaq
- Market Cap
- EXAS 9.9B
- EXP 6.4B
- IPO Year
- EXAS N/A
- EXP 1994
- Fundamental
- Price
- EXAS $52.99
- EXP $213.76
- Analyst Decision
- EXAS Strong Buy
- EXP Buy
- Analyst Count
- EXAS 20
- EXP 9
- Target Price
- EXAS $70.26
- EXP $262.78
- AVG Volume (30 Days)
- EXAS 2.9M
- EXP 443.1K
- Earning Date
- EXAS 08-06-2025
- EXP 07-29-2025
- Dividend Yield
- EXAS N/A
- EXP 0.46%
- EPS Growth
- EXAS N/A
- EXP 1.18
- EPS
- EXAS N/A
- EXP 13.77
- Revenue
- EXAS $2,828,128,000.00
- EXP $2,260,508,000.00
- Revenue This Year
- EXAS $14.61
- EXP $2.63
- Revenue Next Year
- EXAS $12.65
- EXP $5.43
- P/E Ratio
- EXAS N/A
- EXP $15.65
- Revenue Growth
- EXAS 11.57
- EXP 0.05
- 52 Week Low
- EXAS $39.97
- EXP $191.91
- 52 Week High
- EXAS $72.83
- EXP $321.93
- Technical
- Relative Strength Index (RSI)
- EXAS 48.51
- EXP 52.13
- Support Level
- EXAS $51.37
- EXP $211.38
- Resistance Level
- EXAS $55.90
- EXP $228.82
- Average True Range (ATR)
- EXAS 2.37
- EXP 6.13
- MACD
- EXAS -0.00
- EXP 1.79
- Stochastic Oscillator
- EXAS 39.67
- EXP 49.02
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.